Lin Peng

机构：Sun Yat-sen University, Sichuan University, The First Affiliated Hospital, Sun Yat-sen University, State Key Laboratory of Oral Diseases · ORCID：0000-0002-3418-7569

发表论文 100 篇 · 总被引 770 次 · h-index 15

代表论文

• Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis (2024 · BMC Cancer · 被引 18)
• Preliminary results from the multicenter, randomized phase III trial (SCIENCE): Comparing chemotherapy plus sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant treatment in resectable locally advanced esophageal squamous cell carcinoma. (2025 · Journal of Clinical Oncology · 被引 10)
• Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study (2025 · Annals of Surgical Oncology · 被引 6)
• Global trends of esophageal cancer among individuals over 60 years: an epidemiological analysis from 1990 to 2050 based on the global burden of disease study 1990-2021 (2025 · Oncology Reviews · 被引 5)
• Fluorescence quantitative assessment of blood perfusion in the gastric conduit to reduce anastomotic leakage after esophagectomy: a randomized controlled trial (2025 · Surgical Endoscopy · 被引 4)
• Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study (2024 · Translational Lung Cancer Research · 被引 4)